MA26523A1 - Modification thermodynamiquement stable de 1-(4-carbazolyloxy)-3-(2-(2-methoxyphenoxy) ethylamino)-2-propanole, procede pour sa preparation et compositions pharmaceutiques le comprenant - Google Patents

Modification thermodynamiquement stable de 1-(4-carbazolyloxy)-3-(2-(2-methoxyphenoxy) ethylamino)-2-propanole, procede pour sa preparation et compositions pharmaceutiques le comprenant

Info

Publication number: MA26523A1
Authority: MA; Morocco
Prior art keywords: carbazolyloxy; propanole; methoxyphenoxy; ethylamino; preparation
Prior art date: 1997-07-22

Application number

MA25178A

Other languages

English (en)

Inventor

Erhard Reinholz

Peter Beyer

Original Assignee

Boehringer Mannheim Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-22

Filing date

1998-07-20

Publication date

2004-12-20

1998-07-20 Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh

2004-12-20 Publication of MA26523A1 publication Critical patent/MA26523A1/fr

Links

-1 4-CARBAZOLYLOXY Chemical class 0.000 title 2
238000000034 method Methods 0.000 title 1
230000004048 modification Effects 0.000 title 1
238000012986 modification Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

MA25178A 1997-07-22 1998-07-20 Modification thermodynamiquement stable de 1-(4-carbazolyloxy)-3-(2-(2-methoxyphenoxy) ethylamino)-2-propanole, procede pour sa preparation et compositions pharmaceutiques le comprenant MA26523A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP97112491A EP0893440A1 (fr)	1997-07-22	1997-07-22	Une modification thermodynamique stabilisée de 1-(4-carbazolyloxy)-3[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, un procédé pour sa préparation et une composition pharmaceutique qui la contient

Publications (1)

Publication Number	Publication Date
MA26523A1 true MA26523A1 (fr)	2004-12-20

Family

ID=8227094

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25178A MA26523A1 (fr)	1997-07-22	1998-07-20	Modification thermodynamiquement stable de 1-(4-carbazolyloxy)-3-(2-(2-methoxyphenoxy) ethylamino)-2-propanole, procede pour sa preparation et compositions pharmaceutiques le comprenant

Country Status (31)

Country	Link
EP (2)	EP0893440A1 (fr)
JP (1)	JP2001510824A (fr)
KR (1)	KR100336229B1 (fr)
CN (1)	CN1125047C (fr)
AR (1)	AR015133A1 (fr)
AT (1)	ATE236123T1 (fr)
AU (1)	AU740453B2 (fr)
BR (1)	BR9810776A (fr)
CA (1)	CA2296637C (fr)
CZ (1)	CZ296947B6 (fr)
DE (1)	DE69812964T2 (fr)
DK (1)	DK1000027T3 (fr)
ES (1)	ES2195366T3 (fr)
HR (1)	HRP980406A2 (fr)
HU (1)	HUP0003198A3 (fr)
IL (1)	IL133677A (fr)
MA (1)	MA26523A1 (fr)
MY (1)	MY117734A (fr)
NO (1)	NO313588B1 (fr)
NZ (1)	NZ502136A (fr)
PE (1)	PE96999A1 (fr)
PL (1)	PL191602B1 (fr)
PT (1)	PT1000027E (fr)
RU (1)	RU2202542C2 (fr)
SI (1)	SI1000027T1 (fr)
TR (1)	TR200000148T2 (fr)
TW (1)	TW505631B (fr)
UY (1)	UY25108A1 (fr)
WO (1)	WO1999005105A1 (fr)
YU (1)	YU2200A (fr)
ZA (1)	ZA986475B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2227206T3 (es) *	2000-04-03	2005-04-01	F. Hoffmann-La Roche Ag	Soluciones concentradas de carvedilol.
EP1655285A1 (fr) *	2000-06-28	2006-05-10	Teva Pharmaceutical Industries Ltd.	Procédé de préparation d'une forme crystalline de carvedilol (forme II)
US6699997B2 (en)	2000-06-28	2004-03-02	Teva Pharmaceutical Industries Ltd.	Carvedilol
DE60212130D1 (en) *	2001-07-13	2006-07-20	Smithkline Beecham Corp	Carvedilolpolymorph
EP1429734B1 (fr)	2001-09-21	2007-12-26	Egalet A/S	Dispersions solides a liberation controlee de carvedilole
ES2291503T3 (es) *	2001-09-28	2008-03-01	F. Hoffmann-La Roche Ag	Formas pseudopolimorficas de carvedilol.
PL371409A1 (en) *	2002-01-15	2005-06-13	Teva Pharmaceutical Industries Ltd.	Crystalline solids of carvedilol and processes for their preparation
WO2003092622A2 (fr) *	2002-04-30	2003-11-13	Sb Pharmco Puerto Rico Inc.	Monocitrate monohydrate de carvedilol
CA2492084A1 (fr) *	2002-06-27	2004-01-08	Sb Pharmco Puerto Rico Inc.	Hydobromure de carvedilol
AU2003248746B2 (en) *	2002-06-27	2009-01-08	Smithkline Beecham (Cork) Limited	Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
WO2004041252A1 (fr) *	2002-11-08	2004-05-21	Egalet A/S	Compositions de carvedilol a liberation commandee
US8877241B2 (en)	2003-03-26	2014-11-04	Egalet Ltd.	Morphine controlled release system
WO2004094378A1 (fr) *	2003-04-21	2004-11-04	Matrix Laboratories Ltd	Procede de fabrication de carvedilol, forme-ii
SI21616A (sl) *	2003-09-02	2005-04-30	Krka, Tovarna Zdravil, D.D., Novo Mesto	Nove kristalne oblike karvedilola
US7750036B2 (en)	2003-11-25	2010-07-06	Sb Pharmco Puerto Rico Inc.	Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
PL1838670T3 (pl) *	2004-12-09	2010-03-31	Zach System Spa	Sposób wytwarzania karwedilolu i jego enancjomerów
WO2006135757A1 (fr) *	2005-06-09	2006-12-21	Teva Pharmaceutical Industries Ltd.	Formes cristallines du carvedilol et leurs procedes de preparation
EP1991527A2 (fr)	2006-06-28	2008-11-19	Teva Pharmaceutical Industries Ltd	Formes polymorphes de carvédilol phosphate
RU2366653C2 (ru) *	2006-07-03	2009-09-10	Ооо "Нанокриохимия"	Способ получения рентгеноаморфной модификации карведилола
US20080249317A1 (en) *	2007-04-04	2008-10-09	Apotex Inc.	Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
NZ580972A (en)	2007-06-04	2012-02-24	Egalet Ltd	Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (fr)	2009-02-06	2010-08-12	Egalet A/S	Composition à libération immédiate résistant à une maltraitance par prise d'alcool
EP2445487A2 (fr)	2009-06-24	2012-05-02	Egalet Ltd.	Formulations à libération contrôlée

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2815926A1 (de) *	1978-04-13	1979-10-18	Boehringer Mannheim Gmbh	Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2805404A1 (de) *	1978-02-09	1979-08-16	Merck Patent Gmbh	1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3319027A1 (de) *	1983-05-26	1984-11-29	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

1997
- 1997-07-22 EP EP97112491A patent/EP0893440A1/fr not_active Withdrawn
1998
- 1998-07-15 MY MYPI98003245A patent/MY117734A/en unknown
- 1998-07-15 PE PE1998000626A patent/PE96999A1/es not_active Application Discontinuation
- 1998-07-18 PT PT98937576T patent/PT1000027E/pt unknown
- 1998-07-18 HU HU0003198A patent/HUP0003198A3/hu unknown
- 1998-07-18 SI SI9830442T patent/SI1000027T1/xx unknown
- 1998-07-18 IL IL13367798A patent/IL133677A/en not_active IP Right Cessation
- 1998-07-18 DE DE69812964T patent/DE69812964T2/de not_active Expired - Fee Related
- 1998-07-18 EP EP98937576A patent/EP1000027B1/fr not_active Expired - Lifetime
- 1998-07-18 DK DK98937576T patent/DK1000027T3/da active
- 1998-07-18 RU RU2000103033/04A patent/RU2202542C2/ru not_active IP Right Cessation
- 1998-07-18 PL PL338432A patent/PL191602B1/pl unknown
- 1998-07-18 NZ NZ502136A patent/NZ502136A/en unknown
- 1998-07-18 BR BR9810776-3A patent/BR9810776A/pt not_active Application Discontinuation
- 1998-07-18 TR TR2000/00148T patent/TR200000148T2/xx unknown
- 1998-07-18 WO PCT/EP1998/004475 patent/WO1999005105A1/fr not_active Ceased
- 1998-07-18 YU YU2200A patent/YU2200A/sh unknown
- 1998-07-18 KR KR1020007000667A patent/KR100336229B1/ko not_active Expired - Fee Related
- 1998-07-18 CN CN98807436A patent/CN1125047C/zh not_active Expired - Fee Related
- 1998-07-18 AU AU86319/98A patent/AU740453B2/en not_active Ceased
- 1998-07-18 ES ES98937576T patent/ES2195366T3/es not_active Expired - Lifetime
- 1998-07-18 JP JP2000504104A patent/JP2001510824A/ja active Pending
- 1998-07-18 CZ CZ20000221A patent/CZ296947B6/cs not_active IP Right Cessation
- 1998-07-18 CA CA002296637A patent/CA2296637C/fr not_active Expired - Fee Related
- 1998-07-18 AT AT98937576T patent/ATE236123T1/de not_active IP Right Cessation
- 1998-07-18 TW TW087111738A patent/TW505631B/zh not_active IP Right Cessation
- 1998-07-20 MA MA25178A patent/MA26523A1/fr unknown
- 1998-07-21 ZA ZA9806475A patent/ZA986475B/xx unknown
- 1998-07-21 AR ARP980103547A patent/AR015133A1/es unknown
- 1998-07-22 HR HR97112491.2A patent/HRP980406A2/hr not_active Application Discontinuation
- 1998-07-22 UY UY25108A patent/UY25108A1/es not_active IP Right Cessation
2000
- 2000-01-21 NO NO20000301A patent/NO313588B1/no unknown

Also Published As

Publication number	Publication date
CA2296637A1 (fr)	1999-02-04
HUP0003198A3 (en)	2002-10-28
HUP0003198A2 (en)	2001-03-28
CN1125047C (zh)	2003-10-22
JP2001510824A (ja)	2001-08-07
SI1000027T1 (en)	2003-10-31
EP0893440A1 (fr)	1999-01-27
DE69812964T2 (de)	2004-03-04
MY117734A (en)	2004-07-31
IL133677A (en)	2004-06-01
PL191602B1 (pl)	2006-06-30
NO20000301L (no)	2000-01-21
PE96999A1 (es)	1999-10-12
ZA986475B (en)	2000-01-21
CN1264366A (zh)	2000-08-23
DE69812964D1 (de)	2003-05-08
KR100336229B1 (ko)	2002-05-09
AR015133A1 (es)	2001-04-18
NO313588B1 (no)	2002-10-28
CZ2000221A3 (cs)	2000-05-17
HRP980406A2 (en)	1999-04-30
IL133677A0 (en)	2001-04-30
RU2202542C2 (ru)	2003-04-20
TW505631B (en)	2002-10-11
EP1000027A1 (fr)	2000-05-17
NZ502136A (en)	2002-05-31
KR20010022097A (ko)	2001-03-15
AU8631998A (en)	1999-02-16
WO1999005105A1 (fr)	1999-02-04
CA2296637C (fr)	2005-11-15
CZ296947B6 (cs)	2006-08-16
TR200000148T2 (tr)	2000-07-21
ATE236123T1 (de)	2003-04-15
DK1000027T3 (da)	2003-07-21
PT1000027E (pt)	2003-07-31
AU740453B2 (en)	2001-11-01
PL338432A1 (en)	2000-11-06
YU2200A (sh)	2002-03-18
NO20000301D0 (no)	2000-01-21
EP1000027B1 (fr)	2003-04-02
HK1029339A1 (en)	2001-03-30
ES2195366T3 (es)	2003-12-01
BR9810776A (pt)	2000-09-19
UY25108A1 (es)	2000-12-29

Similar Documents

Publication	Publication Date	Title
MA26523A1 (fr)	2004-12-20	Modification thermodynamiquement stable de 1-(4-carbazolyloxy)-3-(2-(2-methoxyphenoxy) ethylamino)-2-propanole, procede pour sa preparation et compositions pharmaceutiques le comprenant
MA26536A1 (fr)	2004-12-20	Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation.
DZ3191A1 (fr)	2001-01-11	Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
HUP0001539A3 (en)	2003-01-28	2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
MA26526A1 (fr)	2004-12-20	Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26508A1 (fr)	2004-12-20	Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26415A1 (fr)	2004-12-20	Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA25493A1 (fr)	2002-07-01	Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
MA26427A1 (fr)	2004-12-20	Trihydrate de mesylate de 5-(2-(4-(1,2-benzisothiazole-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indole-2-one, procede pour sa preparation et compositions pharmaceutiques le contenant
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26471A1 (fr)	2004-12-20	Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
NO306783B1 (no)	1999-12-20	Fremgangsmåte for fremstilling av 1-(2'-deoksy-2',2'-difluor-D-ribofuranosyl-4-aminopyrimidin-2-on)hydroklorid
FR2780728B1 (fr)	2001-02-16	Sel de paroxetine nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
MA25223A1 (fr)	2001-07-02	Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
MA26519A1 (fr)	2004-12-20	Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA25418A1 (fr)	2002-04-01	Procede pour produire des preparations pharmaceutiques solides rapidement decomposables.
FR2791059B1 (fr)	2005-04-01	Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee
FI20011433L (fi)	2001-07-02	Menetelmä 2,5,diamino-4,6-diklooripyrimidiinin valmistamiseksi
EE200000651A (et)	2002-04-15	Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
MA26609A1 (fr)	2004-12-20	Derives de retiferol, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26708A1 (fr)	2004-12-20	Derive d'indole nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant